본문 바로가기
KERD
논문KCI 등재

Distinct binding conformations of epinephrine with α- and β-adrenergic receptors

Lou Jian-Shu|Su Minfei|Wang Jinan|Do Hung Nguyen|Miao Yinglong|Huang Xin-Yun
생화학분자생물학회 (Korean Society Of Biochemistry And Molecular Biology)|2024.12|Experimental and Molecular Medicine|제56권 |pp. 1952-1966|DOI 10.1038/s12276-024-01296-x

4

조회

0

다운로드

0

인용

0

참고문헌

주제분류생화학

초록

Agonists targeting α2-adrenergic receptors (ARs) are used to treat diverse conditions, including hypertension, attention-deficit/hyperactivity disorder, pain, panic disorders, opioid and alcohol withdrawal symptoms, and cigarette cravings. These receptors transduce signals through heterotrimeric Gi proteins. Here, we elucidated cryo-EM structures that depict α2A-AR in complex with Gi proteins, along with the endogenous agonist epinephrine or the synthetic agonist dexmedetomidine. Molecular dynamics simulations and functional studies reinforce the results of the structural revelations. Our investigation revealed that epinephrine exhibits different conformations when engaging with α-ARs and β-ARs. Furthermore, α2A-AR and β1-AR (primarily coupled to Gs, with secondary associations to Gi) were compared and found to exhibit different interactions with Gi proteins. Notably, the stability of the epinephrine–α2A-AR–Gi complex is greater than that of the dexmedetomidine–α2A-AR–Gi complex. These findings substantiate and improve our knowledge on the intricate signaling mechanisms orchestrated by ARs and concurrently shed light on the regulation of α-ARs and β-ARs by epinephrine.

Abstract

Agonists targeting α2-adrenergic receptors (ARs) are used to treat diverse conditions, including hypertension, attention-deficit/hyperactivity disorder, pain, panic disorders, opioid and alcohol withdrawal symptoms, and cigarette cravings. These receptors transduce signals through heterotrimeric Gi proteins. Here, we elucidated cryo-EM structures that depict α2A-AR in complex with Gi proteins, along with the endogenous agonist epinephrine or the synthetic agonist dexmedetomidine. Molecular dynamics simulations and functional studies reinforce the results of the structural revelations. Our investigation revealed that epinephrine exhibits different conformations when engaging with α-ARs and β-ARs. Furthermore, α2A-AR and β1-AR (primarily coupled to Gs, with secondary associations to Gi) were compared and found to exhibit different interactions with Gi proteins. Notably, the stability of the epinephrine–α2A-AR–Gi complex is greater than that of the dexmedetomidine–α2A-AR–Gi complex. These findings substantiate and improve our knowledge on the intricate signaling mechanisms orchestrated by ARs and concurrently shed light on the regulation of α-ARs and β-ARs by epinephrine.

참고문헌 (69)

  1. von Euler, U. S., "Adrenergic neurotransmitter functions", Science, 173, pp.202~206 (1971)[DOI]
  2. Philipp, M., "Adrenergic receptor knockout mice: distinct functions of 9receptor subtypes", Pharm. Ther, 101, pp.65~74 (2004)[DOI]
  3. Brede, M., "alpha2-adrenergic receptor subtypes—novel functions uncovered in gene-targeted mouse models", Biol. Cell, 96, pp.343~348 (2004)[DOI]
  4. Giovannitti, J. A. Jr, "Alpha-2 adrenergic receptor agonists : a review of current clinical applications", Anesth. Prog, 62, pp.31~39 (2015)[DOI]
  5. Keating, G. M., "Dexmedetomidine: a review of its use for sedation in the intensive care setting", Drugs, 75, pp.1119~1130 (2015)[DOI]
  6. Pichot, C., "Dexmedetomidine and clonidine: from second- to first-line sedative agents in the critical care setting?", J. Intensive Care Med, 27, pp.219~237 (2012)[DOI]
  7. Weerink, M. A. S., "Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine", Clin. Pharmacokinet, 56, pp.893~913 (2017)[DOI]
  8. Nguyen, V., "Alpha-2 agonists", Anesthesiol. Clin, 35, pp.233~245 (2017)[DOI]
  9. Preskorn, S. H., "Effect of sublingual dexmedetomidine vs placebo on acute agitation associated with bipolar disorder : a randomized clinical trial", JAMA, 327, pp.727~736 (2022)[DOI]
  10. Scullion, G. A., "Chronic treatment with the alpha2-adrenoceptor antagonist fluparoxan prevents agerelated deficits in spatial working memory in APPxPS1 transgenic mice without altering beta-amyloid plaque load or astrocytosis", Neuropharmacology, 60, pp.223~234 (2011)[DOI]
  11. Kobilka, B. K., "Structural insights into adrenergic receptor function and pharmacology", Trends Pharmacol. Sci, 32, pp.213~218 (2011)[DOI]
  12. "Epinephrine in StatPearls" (2023)[URL]
  13. Su, M., "Structural basis of agonist specificity of alpha(1A)-adrenergic receptor", Nat. Commun, 14, pp.4819~ (2023)[DOI]
  14. Xu, X., "Binding pathway determines norepinephrine selectivity for the human beta1AR over beta2AR", Cell Res, 31, pp.569~579 (2021)[DOI]
  15. Ring, A. M., "Adrenaline-activated structure of beta2-adrenoceptor stabilized by an engineered nanobody", Nature, 502, pp.575~579 (2013)[DOI]
  16. Kompa, A. R., "Desensitization of cardiac beta-adrenoceptor signaling with heart failure produced by myocardial infarction in the rat. Evidence for the role of Gi but not Gs or phosphorylating proteins", J. Mol. Cell Cardiol, 31, pp.1185~1201 (1999)[DOI]
  17. Martin, N. P., "PKA mediated phosphorylation of the beta1-adrenergic receptor promotes Gs", Gi switching, 2004, pp.16, 1397~1403
  18. Belevych, A. E., "Protein kinase C regulates functional coupling of beta1-adrenergic receptors to Gi", o-mediated responses in cardiac myocytes, 2004, pp.18, 367~369
  19. Wang, J., "Galphai is required for carvedilol-induced beta1 adrenergic receptor beta-arrestin biased signaling", Nat. Commun, 8, pp.1706~ (2017)[DOI]
  20. Dwivedi, H., "GPCR signaling : the interplay of galphai and beta-arrestin", Curr. Biol, 28, pp.R324~R327 (2018)[DOI]
  21. Alegre, K. O., "Structural basis and mechanism of activation of two different families of G proteins by the same GPCR", Nat. Struct. Mol. Biol, 28, pp.936~944 (2021)[DOI]
  22. Miao, Y., "Gaussian accelerated molecular dynamics:unconstrained enhanced sampling and free energy calculation", J. Chem. Theory Comput, 11, pp.3584~3595 (2015)[DOI]
  23. Wang, J. N., "Gaussian accelerated molecular dynamics: principles and applications", Wires Comput Mol. Sci, 11, pp.e1521~ (2021)[DOI]
  24. Miao, Y., "Graded activation and free energy landscapes of a muscarinic G-protein–coupled receptor", Proc. Natl. Acad. Sci, 113, pp.12162~12167 (2016)[DOI]
  25. Su, M., "Structures of beta1-adrenergic receptor in complex with Gs and ligands of different efficacies", Nat. Commun, 13, pp.4095~ (2022)[DOI]
  26. Draper-Joyce, C. J., "Positive allosteric mechanisms of adenosine A1 receptor mediated analgesia", Nature, 597, pp.571~576 (2021)[DOI]
  27. Su, M., "Structural basis of the activation of heterotrimeric Gs-protein by isoproterenol-bound beta1-adrenergic receptor", Mol. Cell, 80, pp.59~71 (2020)[DOI]
  28. Liu, S., "Differential activation mechanisms of lipid GPCRs by lysophosphatidic acid and sphingosine 1-phosphate", Nat. Commun, 13, pp.731~ (2022)[DOI]
  29. Zheng, S. Q., "MotionCor2 : anisotropic correction of beam-induced motion for improved cryo-electron microscopy", Nat. Methods, 14, pp.331~332 (2017)[DOI]
  30. Zivanov, J., "New tools for automated high-resolution cryo-EM structure determination in RELION-3", Elife, 7 (2018)[DOI]
  31. Zivanov, J., "A Bayesian approach to beam-induced motion correction in cryo-EM single-particle analysis", IUCrJ, 6, pp.5~17 (2019)[DOI]
  32. Rohou, A., "CTFFIND4: fast and accurate defocus estimation from electron micrographs", J. Struct. Biol, 192, pp.216~221 (2015)[DOI]
  33. Punjani, A., "cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination", Nat. Methods, 14, pp.290~296 (2017)[DOI]
  34. Emsley, P., "Coot: model-building tools for molecular graphics", Acta Crystallogr. D. Biol. Crystallogr, 60, pp.2126~2132 (2004)[DOI]
  35. Adams, P. D., "PHENIX : a comprehensive Python-based system for macro molecular structure solution", Acta Crystallogr. D. Biol. Crystallogr, 66, pp.213~221 (2010)[DOI]
  36. Friesner, R. A., "Extra precision glide : docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes", J. Med. Chem, 49, pp.6177~6196 (2006)[DOI]
  37. Chen, V. B., "MolProbity : all-atom structure validation for macromolecular crystallography", Acta Crystallogr. D. Biol. Crystallogr, 66, pp.12~21 (2010)[DOI]
  38. Waterhouse, A., "SWISS-MODEL : homology modelling of protein structures and complexes", Nucleic Acids Res, 46, pp.W296~W303 (2018)[DOI]
  39. Lee, J., "CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM", OpenMM simulations using the CHARMM36 additive force field, 2016, pp.12, 405~413
  40. Vanommeslaeghe, K., "CHARMM additive and polarizable force f ields for biophysics and computer-aided drug design", Biochim. Biophys. Acta (BBA)- Gen. Subj, 1850, pp.861~871 (2015)[DOI]
  41. Huang, J., "CHARMM36m : an improved force field for folded and intrinsi cally disordered proteins", Nat. Methods, 14, pp.71~ (2017)[DOI]
  42. Klauda, J. B., "Update of the CHARMM all-atom additive force field for lipids : validation on six lipid types", J. Phys. Chem. B, 114, pp.7830~7843 (2010)[DOI]
  43. Vanommeslaeghe, K., "Automation of the CHARMM general force field (CGenFF) II: assignment of bonded parameters and partial atomic charges", J. Chem. Inf. Model, 52, pp.3155~3168 (2012)[DOI]
  44. Kumar, A., "FFParam: standalone package for CHARMM additive and drude polarizable force field parametrization of small molecules", J. Comput. Chem, 41, pp.958~970 (2020)[DOI]
  45. Phillips, J. C., "Scalable molecular dynamics with NAMD", J. Comput. Chem, 26, pp.1781~1802 (2005)[DOI]
  46. Darden, T., "Particle mesh Ewald: An N⋅ log (N) method for Ewald sums in large systems", J. Chem. Phys, 98, pp.10089~ (1993)[DOI]
  47. Case, D. A, "Amber 2020" (2020), University of California
  48. Roe, D. R., "PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data", J. Chem. Theory Comput, 9, pp.3084~3095 (2013)[DOI]
  49. Hisano, Y., "Lysolipid receptor cross-talk regulates lymphatic endothelial junctions in lymph nodes", J. Exp. Med, 216, pp.1582~1598 (2019)[DOI]
  50. Huang, J., "Pivotal role of extended linker 2 in the activation of Galpha by G protein-coupled receptor", J. Biol. Chem, 290, pp.272~283 (2015)[DOI]
  51. Manglik, A., "Nanobodies to study G Protein-coupled receptor structure and function", Annu Rev. Pharm. Toxicol, 57, pp.19~37 (2017)[DOI]
  52. Ballesteros, J. A. W. H., "Integrated methods for the construction of three dimensional models and computational probing of structure-function relations in G protein-coupled receptors", Methods Neurosci, 25, pp.366~428 (1995)
  53. Suryanarayana, S., "A point mutation in the seventh hydrophobic domain of the alpha 2 adrenergic receptor increases its affinity for a family of beta receptor antagonists", J. Biol. Chem, 266, pp.15488~15492 (1991)
  54. Suryanarayana, S., "Amino acid substitutions at position 312 in the seventh hydrophobic segment of the beta 2-adrenergic receptor modify ligand binding specificity", Mol. Pharm, 44, pp.111~114 (1993)
  55. Wu, Y., "Ligands of adrenergic receptors: a structural point of view", Biomolecules, 11 (2021)[DOI]
  56. GTPgammaS binding, "Biochem. Pharmacol", 1998, 1035~1043, 10.1016[DOI]
  57. GTPgammaS binding by recombinant alpha2-adrenoceptors, "Eur. J. Pharm", 1998, 275~279, 10.1016[DOI]
  58. Tan, C. M., "Hetero zygous alpha 2A-adrenergic receptor mice unveil unique therapeutic benefits of partial agonists", Proc. Natl Acad. Sci. USA, 99, pp.12471~12476 (2002)[DOI]
  59. Yuan, D., "Activation of the alpha2B adrenoceptor by the sedative sym patholytic dexmedetomidine", Nat. Chem. Biol, 16, pp.507~512 (2020)[DOI]
  60. Xu, J., "Structural insights into ligand recognition, activation, and signaling of the alpha2A adrenergic receptor", Sci. Adv, 8, pp.eabj5347~ (2022)[DOI]
  61. Liapakis, G., "The forgotten serine. A critical role for Ser-2035.42 in ligand binding to and activation of the beta 2-adrenergic receptor", J. Biol. Chem, 275, pp.37779~37788 (2000)[DOI]
  62. Qu, L., "Structural basis of the diversity of adrenergic receptors", Cell Rep, 29, pp.2929~2935 (2019)[DOI]
  63. Zhou, Q., "Common activation mechanism of class A GPCRs", Elife, 8 (2019)[DOI]
  64. Asano, T., "Activation of the inhibitory GTP binding protein of adenylate cyclase, Gi, by beta-adrenergic receptors in recon stituted phospholipid vesicles", J. Biol. Chem, 259, pp.9351~9354 (1984)
  65. Sun, D., "Probing Galphai1 protein activation at single-amino acid resolution", Nat. Struct. Mol. Biol, 22, pp.686~694 (2015)[DOI]
  66. Kang, Y., "Cryo-EM structure of human rhodopsin bound to an inhibitory G protein", Nature, 558, pp.553~558 (2018)[DOI]
  67. Wall, M. A., "The structure of the G protein heterotrimer Gi alpha 1 beta 1 gamma 2", Cell, 83, pp.1047~1058 (1995)
  68. Wang, C. D., "Site-directed mutagenesis of alpha 2A adrenergic receptors : identification of amino acids involved in ligand binding and receptor activation by agonists", Mol. Pharm, 40, pp.168~179 (1991)
  69. Fink, E. A., "Structure-based discovery of nonopioid analgesics acting through the alpha(2A)-adrenergic receptor", Science, 377, pp.eabn7065~ (2022)[DOI]

관련 논문AI추천

Structure-based drug discovery of a corticotropin-releasing hormone receptor 1 antagonist using an X-ray free-electron laser정은지, 하고은, Abrahamsson Alva, Chang Nienping, Cho Hyun-Soo, Cho Yongju, Kim B. Moon, Kim Byeong Wook, Kim Hoyoung, Kim Hyo-Ji, Kim Jun-Woo, Kim Ki Hun, Kim Si Hyun, Kim Sung Hwan, Lee Jaeick, Lee Jee-Young, Lee Sang Jae, Lim Taehyun, Park Jaehyun, Park Sehan생화학분자생물학회 · Experimental and Molecular Medicine2023 · 제55권 Structural studies of serotonin receptor family김국래, Apeksha Parajulee생화학분자생물학회 · BMB Reports2023 · 제56권 제10호Structural insights into GPCR signaling activated by peptide ligands: from molecular mechanism to therapeutic applicationBae Jungnam, Choi Chulwon, Choi Hee-Jung, Kim Jeesoo, Kim Jinuk생화학분자생물학회 · Experimental and Molecular Medicine2025 · 제57권 Probing spatiotemporally organized GPCR signaling using genetically encoded molecular toolsKwon Yonghoon, Mehta Sohum, Zhang Jin생화학분자생물학회 · Experimental and Molecular Medicine2025 · 제57권 The multifaceted functions of β-arrestins and their therapeutic potential in neurodegenerative diseasesKee Teresa R., Khan Sophia A., Kim Yenna K., Masters Brianna M., McGill Percy Kyle C., Neidhart Maya B., Woo Jung-A A., Zhao Victoria K.생화학분자생물학회 · Experimental and Molecular Medicine2024 · 제56권 Cryo-EM as a powerful tool for drug discovery: recent structural based studies of SARS-CoV-2정현석, Kim Han-ul한국현미경학회 · Applied Microscopy2021 · 제51권 제3호

이 간행물의 다른 논문 (218건)

Big data and deep learning for RNA biologyJeon Hyeonseong, Baek Daehyun, Hwang Hyeonseo, Yeo Nagyeongpp. 1-29RGS19 activates the MYH9/β-catenin/c-Myc positive feedback loop in hepatocellular carcinomaXu Yanan, Ke Shanjia, Lu Shounan, Bai Miaoyu, Yu Hongjun, Yin Bing, Wang Chaoqun, Feng Zhigang, Li Zihao, Huang Jingjing, Li Xinglong, Qian Baolin, Hua Yongliang, Fu Yao, Sun Bei, Wu Yaohua, Ma Yongpp. 1-14Molecular mechanisms of circular RNA translationKim Yoon Ki, Hwang Hyun Jungpp. 1-9The m6A writer RBM15 drives the growth of triple-negative breast cancer cells through the stimulation of serine and glycine metabolismKim Ho, Yun Hye Jin, 이종호, Lee Su Bin, Kim Seok-Ho, Park Yun-Yong, Park Su Hwan, Ju Jin-Sung, Woo Hyunmin, Győrffy Balázs, Kim Eun-jeong, Han Hee Dong, Eyun Seong-ilpp. 1-15Neuron type-specific optogenetic stimulation for differential stroke recovery in chronic capsular infarctKim Ra Gyung, Cho Jongwook, Park Ji-Young, Kim Young Ro, Lee Min-Cheol, Kim Hyoung-Ihlpp. 1-11
원문 보기